PT99569A - Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem

Info

Publication number: PT99569A
Authority: PT; Portugal
Prior art keywords: image; eritromycin; derivatives; pharmaceutical compositions; compositions containing
Prior art date: 1990-11-21

Application number

PT99569A

Other languages

English (en)

Other versions

PT99569B (pt

Inventor

Jean-Francois Chantot

Constantin Agouridas

Yannick Benedetti

Alexis Denis

Claude Fromentin

Odile Le Martret

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-21

Filing date

1991-11-21

Publication date

1992-10-30

1990-11-21 Priority claimed from FR9014499A external-priority patent/FR2669337B1/fr

1991-05-27 Priority claimed from FR9106333A external-priority patent/FR2677025B1/fr

1991-08-29 Priority claimed from FR9110728A external-priority patent/FR2680790B1/fr

1991-11-21 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1992-10-30 Publication of PT99569A publication Critical patent/PT99569A/pt

1999-04-30 Publication of PT99569B publication Critical patent/PT99569B/pt

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
239000004215 Carbon black (E152) Substances 0.000 abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
229930195733 hydrocarbon Natural products 0.000 abstract 2
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
QPILZZVXGUNELN-UHFFFAOYSA-M sodium;4-amino-5-hydroxynaphthalene-2,7-disulfonate;hydron Chemical compound [Na+].OS(=O)(=O)C1=CC(O)=C2C(N)=CC(S([O-])(=O)=O)=CC2=C1 QPILZZVXGUNELN-UHFFFAOYSA-M 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Diaphragms For Electromechanical Transducers (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

PT99569A 1990-11-21 1991-11-21 Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem PT99569B (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9014499A FR2669337B1 (fr)	1990-11-21	1990-11-21	Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
FR9106333A FR2677025B1 (fr)	1991-05-27	1991-05-27	Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
FR9110728A FR2680790B1 (fr)	1991-08-29	1991-08-29	Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.

Publications (2)

Publication Number	Publication Date
PT99569A true PT99569A (pt)	1992-10-30
PT99569B PT99569B (pt)	1999-04-30

Family

ID=27252354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99569A PT99569B (pt)	1990-11-21	1991-11-21	Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem

Country Status (26)

Country	Link
US (3)	US5444051A (pt)
EP (1)	EP0487411B1 (pt)
JP (1)	JP3130097B2 (pt)
KR (1)	KR100189597B1 (pt)
CN (1)	CN1033974C (pt)
AT (1)	ATE133683T1 (pt)
AU (1)	AU640290B2 (pt)
BR (1)	BR9105062A (pt)
CA (1)	CA2055912C (pt)
CZ (1)	CZ290651B6 (pt)
DE (1)	DE69116815T2 (pt)
DK (1)	DK0487411T3 (pt)
ES (1)	ES2082952T3 (pt)
FI (1)	FI102281B (pt)
GR (1)	GR3018848T3 (pt)
HU (1)	HU218787B (pt)
IE (1)	IE74713B1 (pt)
IL (3)	IL99995A (pt)
MA (1)	MA22344A1 (pt)
MX (1)	MX9102159A (pt)
NZ (1)	NZ240684A (pt)
OA (1)	OA09523A (pt)
PL (2)	PL169422B1 (pt)
PT (1)	PT99569B (pt)
RU (1)	RU2100367C1 (pt)
SK (1)	SK281550B6 (pt)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5523399A (en) *	1991-12-27	1996-06-04	Taisho Pharmaceutical Co., Ltd.	5-O-desosaminylerythronolide derivatives
ES2087737T3 (es) *	1992-04-22	1996-07-16	Taisho Pharmaceutical Co Ltd	Un derivado 5-o-desosaminil-eritronoluro a.
FR2697524B1 (fr) *	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2707088B1 (fr) *	1993-07-02	1995-08-25	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
AU671899B2 (en) *	1993-01-26	1996-09-12	Taisho Pharmaceutical Co., Ltd.	5-O-desosaminylerythronolide derivative
FR2702480B1 (fr) *	1993-03-09	1995-04-28	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) *	1993-12-03	1996-01-05	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP931480B1 (en) *	1993-12-08	1997-08-31	Sour Pliva	9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
FR2718450B1 (fr) *	1994-04-08	1997-01-10	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) *	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) *	1994-12-09	1997-01-17	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
IT1276901B1 (it) *	1994-12-13	1997-11-03	Zambon Spa	Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
FR2732684B1 (fr) *	1995-04-06	1997-04-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP2000501077A (ja) *	1995-11-08	2000-02-02	アボツト・ラボラトリーズ	エリスロマイシンａおよびｂの３−デオキシ−３−デスクラジノース誘導体
US5747466A (en) *	1995-11-08	1998-05-05	Abbott Laboratories	3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr)	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) *	1996-02-28	1998-04-03	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
USRE38520E1 (en) *	1996-02-28	2004-05-18	Aventis Pharma S.A.	Erythromycin derivatives, method for preparing same, and use thereof as drugs
US5750510A (en) *	1997-04-04	1998-05-12	Abbott Laboratories	3-descladinose-2,3-anhydroerythromycin derivatives
DE69723848T2 (de) *	1996-05-07	2004-07-01	Abbott Laboratories, Abbott Park	3-descladinose-2,3-anhydroerythromycin-derivate
EP0918783A1 (en) *	1996-05-07	1999-06-02	Abbott Laboratories	6-o-substituted erythromycins and method for making them
FR2751656B1 (fr) *	1996-07-24	1998-10-16	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733439T2 (de) *	1996-09-04	2006-05-04	Abbott Laboratories, Abbott Park	6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) *	1996-09-04	2002-12-16	Ебботт Лабораторіз	6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) *	1996-09-24	1998-09-08	Taisho Pharmaceutical Co., Ltd.	Erythromycin A derivatives
FR2754821B1 (fr) *	1996-10-23	2003-04-04	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2757168B1 (fr) *	1996-12-12	1999-06-11	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2757518B1 (fr) *	1996-12-23	1999-06-11	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) *	1997-02-27	1999-04-30	Hoechst Marion Roussel Inc	Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) *	1997-03-10	1998-09-29	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives
AU6421398A (en) *	1997-03-24	1998-10-20	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives
US5922683A (en) *	1997-05-29	1999-07-13	Abbott Laboratories	Multicyclic erythromycin derivatives
KR20010013660A (ko) *	1997-06-11	2001-02-26	실버스타인 아써 에이.	9-옥심 에리트로마이신 유도체
ZA987689B (en) *	1997-09-02	1999-02-24	Abbott Lab	3-descladinose 6-O substituted erythromycin derivatives
CA2303930A1 (en) *	1997-09-30	1999-04-08	Abbott Laboratories	3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
US6034069A (en) *	1997-09-30	2000-03-07	Abbott Laboratories	3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
CO4990960A1 (es) *	1997-10-29	2000-12-26	Abbott Lab	Derivados de cetolidos 2-halo-6-o sustituidos
US6124269A (en) *	1997-10-29	2000-09-26	Abbott Laboratories	2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) *	1997-10-29	2000-04-04	Abbott Laboratories	6,11-bridged erythromycin derivatives
HN1998000159A (es) *	1997-10-29	1999-02-09	Monsanto Co	Derivados de 9- amino - 3 ceto eritromicina
WO1999021868A1 (fr)	1997-10-29	1999-05-06	Taisho Pharmaceutical Co., Ltd.	Derives d'erythromycine a
AU1504899A (en) *	1997-12-11	1999-06-28	Hokuriku Seiyaku Co. Ltd	Erythromycin derivatives
AP1060A (en) *	1998-01-02	2002-04-23	Pfizer Prod Inc	Novel erythromycin derivatives.
US5955440A (en) *	1998-03-27	1999-09-21	Abbott Laboratories	Macrolide LHRH antagonists
US5972898A (en) *	1998-03-27	1999-10-26	Abbott Laboratories	3',3-N-bis-substituted macrolide LHRH antagonists
HRP980189B1 (en) *	1998-04-06	2004-04-30	Pliva Pharm & Chem Works	Novel 15-membered lactams ketolides
FR2777282B1 (fr) *	1998-04-08	2001-04-20	Hoechst Marion Roussel Inc	Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
JP4573925B2 (ja) *	1998-07-09	2010-11-04	アベンティス・ファーマ・ソシエテ・アノニム	新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) *	1998-07-09	2000-09-01	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) *	1998-07-21	2001-08-10	Hoechst Marion Roussel Inc	Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
IT1301967B1 (it) *	1998-07-30	2000-07-20	Zambon Spa	Derivato di eritromicina ad attivita' antibiotica
US6387885B1 (en) *	1998-08-26	2002-05-14	Abbott Laboratories	3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6020521A (en) *	1998-08-26	2000-02-01	Abbott Laboratories	Macrolide LHRH antagonists
WO2000017218A1 (en)	1998-09-22	2000-03-30	Pfizer Products Inc.	Carbamate and carbazate ketolide antibiotics
USRE39743E1 (en) *	1998-10-15	2007-07-24	Aventis Pharma S.A.	2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) *	1998-10-15	2002-12-06	Hoechst Marion Roussel Inc	Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) *	1998-11-10	2000-05-12	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EE200100245A (et) *	1998-11-03	2002-10-15	Pfizer Products Inc.	Uued makroliidsed antibiootikumid
KR100317907B1 (ko) *	1998-11-24	2001-12-24	김 완 주	신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
ATE344269T1 (de)	1998-12-10	2006-11-15	Pfizer Prod Inc	Carbamat und carbazat ketolid antibiotika
DK1147121T3 (da)	1999-01-27	2004-04-13	Pfizer Prod Inc	Ketolidantibiotika
KR100390159B1 (ko) *	1999-03-09	2003-07-04	(주)니드켐	불소를 함유한 산업폐수 처리제 및 처리방법
US6054435A (en) *	1999-03-19	2000-04-25	Abbott Laboratories	6-O-substituted macrolides having antibacterial activity
US6590083B1 (en)	1999-04-16	2003-07-08	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
AU775637B2 (en)	1999-04-16	2004-08-12	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6514944B2 (en)	1999-04-16	2003-02-04	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6399582B1 (en)	1999-04-16	2002-06-04	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
US6451768B1 (en)	1999-04-16	2002-09-17	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6939861B2 (en) *	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
HRP990116B1 (en) *	1999-04-20	2007-10-31	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6355620B1 (en) *	1999-05-14	2002-03-12	Abbott Laboratories	C-2 modified erythromycin derivatives
EE200100613A (et) *	1999-05-24	2003-02-17	Pfizer Products Inc.	13-metüülerütromütsiini derivaadid
US6420535B1 (en)	1999-06-07	2002-07-16	Abbott Laboratories	6-O-carbamate ketolide derivatives
ATE250076T1 (de) *	1999-06-07	2003-10-15	Abbott Lab	6-o-carbamat ketolide derivate
ID27331A (id) *	1999-09-29	2001-03-29	Pfizer Prod Inc	Pembuatan antibiotik-antibiotik ketolida karbamat
US6569836B2 (en)	1999-12-02	2003-05-27	Abbott Laboratories	6-O-alkyl-2-nor-2-substituted ketolide derivatives
US6946446B2 (en)	2000-02-24	2005-09-20	Abbott Laboratories	Anti-infective agents useful against multidrug-resistant strains of bacteria
WO2001063539A2 (en) *	2000-02-24	2001-08-30	Abbott Laboratories	Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2001261694A (ja) *	2000-03-06	2001-09-26	Pfizer Prod Inc	ケトライド抗生物質
EP1146051A3 (en) *	2000-04-10	2001-10-31	Pfizer Products Inc.	Erythromycin A derivatives
US6472372B1 (en)	2000-12-06	2002-10-29	Ortho-Mcneil Pharmaceuticals, Inc.	6-O-Carbamoyl ketolide antibacterials
US20020132782A1 (en) *	2001-01-18	2002-09-19	Zhenkun Ma	9-amino erythromycin derivatives with antibacterial activity
CA2460947A1 (en)	2001-09-17	2003-03-27	Ortho-Mcneil Pharmaceutical, Inc.	6-o-carbamate-11,12-lacto-ketolide antimicrobials
US8425892B2 (en)	2001-10-29	2013-04-23	Columbia Laboratories, Inc.	Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) *	2001-10-29	2008-12-24	哥伦比亚实验室(百慕大群岛)有限公司	阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
CA2469304A1 (en)	2001-12-05	2003-06-19	Ortho-Mcneil Pharmaceutical, Inc.	6-o acyl ketolide antibacterials
US6841664B2 (en) *	2002-07-25	2005-01-11	Enanra Pharmaceuticals, Inc.	6,11-4-carbon bridged ketolides
US6753318B1 (en) *	2002-07-25	2004-06-22	Enanta Pharmaceuticals, Inc.	6,11-4-carbon bridged erythromycin derivatives
US7910558B2 (en) *	2002-05-13	2011-03-22	Enanta Pharmaceuticals, Inc.	Bridged macrocyclic compounds and processes for the preparation thereof
US6878691B2 (en) *	2002-05-13	2005-04-12	Enanta Pharmaceuticals, Inc.	6-11 bicyclic ketolide derivatives
NZ536402A (en) *	2002-05-13	2006-08-31	Enanta Pharm Inc	6,11 bicyclic erythromycin derivatives
US7273853B2 (en) *	2002-05-13	2007-09-25	Enanta Pharmaceuticals, Inc.	6-11 bicyclic ketolide derivatives
US7064110B2 (en) *	2002-05-13	2006-06-20	Enanta Pharmaceuticals, Inc.	6-11 bicycle ketolide derivatives
US6764998B1 (en)	2003-06-18	2004-07-20	Enanta Pharmaceuticals, Inc.	6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) *	2002-05-13	2006-11-14	Enanta Pharmaceuticals, Inc.	Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7022679B2 (en) *	2002-05-13	2006-04-04	Enanta Pharmaceuticals, Inc.	Processes for the preparation of 6-11 bicyclic erythromycin derivatives
AU2003234650A1 (en)	2002-05-31	2003-12-19	Janssen Pharmaceutica N.V.	3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
US6812216B2 (en) *	2002-06-25	2004-11-02	Enanta Pharmaceuticals, Inc.	11-C-substituted derivatives of clarithromycin
US6750204B2 (en) *	2002-06-25	2004-06-15	Enanta Pharmaceuticals, Inc.	11-C-substituted ketolides
ITMI20021726A1 (it) *	2002-08-01	2004-02-02	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
US7091196B2 (en) *	2002-09-26	2006-08-15	Rib-X Pharmaceuticals, Inc.	Bifunctional heterocyclic compounds and methods of making and using same
US7601695B2 (en) *	2003-03-10	2009-10-13	Optimer Pharmaceuticals, Inc.	Antibacterial agents
US6645941B1 (en)	2003-03-26	2003-11-11	Enanta Pharmaceuticals, Inc.	6,11-3C-bicyclic 9a-azalide derivatives
US20050101548A1 (en) *	2003-09-12	2005-05-12	Xiaodong Lin	Antimicrobial derivatives
US7276487B2 (en) *	2003-09-23	2007-10-02	Enanta Pharmaceuticals, Inc.	9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005030786A1 (en) *	2003-09-25	2005-04-07	Ranbaxy Laboratories Limited	3'-n-substituted-3-o-substituted erythronolide a derivatives
WO2005042554A1 (en) *	2003-10-30	2005-05-12	Rib-X Pharmaceuticals, Inc.	Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) *	2003-11-18	2007-05-17	リブ−エックスファーマシューティカルズ，インコーポレイテッド	二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
AU2003304705A1 (en) *	2003-12-24	2005-08-03	Enanta Pharmaceuticals, Inc.	11-csubsituted erythromycin derivatives
WO2005067564A2 (en) *	2004-01-07	2005-07-28	Enanta Pharmaceuticals, Inc.	6-11 bicyclic erythromycin derivatives
US7265094B2 (en) *	2004-01-09	2007-09-04	Enanta Pharmaceuticals, Inc.	9N-substituted 6-11 bicyclic erythromycin derivatives
JP4737495B2 (ja) *	2004-01-14	2011-08-03	塩野義製薬株式会社	エリスロマイシン誘導体
EP2716647A3 (en) *	2004-02-27	2014-08-20	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
ATE373009T1 (de) *	2004-04-28	2007-09-15	Alembic Ltd	Verfahren zur vorbereitung von telithromycin
EP1781679A1 (en) *	2004-07-28	2007-05-09	Ranbaxy Laboratories Limited	Antibacterial agents
ES2317527T3 (es)	2005-01-13	2009-04-16	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
US7384922B2 (en) *	2005-05-04	2008-06-10	Enanta Pharmaceuticals, Inc.	6-11 bridged oxime erythromycin derivatives
US7582611B2 (en)	2005-05-24	2009-09-01	Pfizer Inc.	Motilide compounds
RU2008106915A (ru) *	2005-07-26	2009-09-10	Меркле Гмбх (De)	Макролидные конъюгаты пирролиновых и индолизиновых соединений
BRPI0619556A2 (pt) *	2005-12-08	2011-10-04	Pfizer	processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina
MX2009005977A (es)	2006-12-05	2009-06-17	Pfizer	Polimorfos de motilida.
CA2733706A1 (en) *	2007-08-10	2009-02-19	Y's Therapeutics Co., Ltd.	Modulation of immune responses by administration of roxithromycin or its derivative
US8354383B2 (en) *	2007-09-17	2013-01-15	Enanta Pharmaceuticals, Inc.	6,11-bridged biaryl macrolides
MX2010002932A (es) *	2007-09-17	2010-05-27	Enanta Pharm Inc	Macrolidos de biarilo con puente en 6, 11.
US8273720B2 (en) *	2007-09-17	2012-09-25	Enanta Pharmaceuticals, Inc.	6,11-bicyclolides: bridged biaryl macrolide derivatives
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
KR101026715B1 (ko) *	2008-04-17	2011-04-14	한수케미칼 주식회사	불소이온 및 시안착화합물과 유리시안 제거제 및 이를이용한 폐수 처리방법
TW200946109A (en)	2008-05-09	2009-11-16	Enanta Pharm Inc	Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN107854477A (zh)	2008-10-24	2018-03-30	森普拉制药公司	使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
US9480679B2 (en)	2009-09-10	2016-11-01	Cempra Pharmaceuticals, Inc.	Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr)	2010-03-22	2016-03-25	Cempra Pharmaceuticals Inc	Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt)	2010-05-20	2016-08-02	Cempra Pharmaceuticals Inc	processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko)	2010-09-10	2013-11-04	셈프라 파마슈티컬스, 인크.	질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
CN103130852B (zh) *	2011-11-25	2016-03-16	上海医药工业研究院	一种红霉素a衍生物、其制备方法、中间体及应用
WO2013148891A1 (en)	2012-03-27	2013-10-03	Cempra Pharmaceuticals, Inc.	Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en)	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en)	2013-03-15	2018-08-09	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents
JP6654576B2 (ja)	2014-05-14	2020-02-26	ダウグローバルテクノロジーズエルエルシー	亜硝酸で後処理される複合ポリアミド膜

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3923784A (en) *	1973-09-10	1975-12-02	Hoffmann La Roche	Erythromycin a derivatives
YU35363B (en) *	1974-01-14	1980-12-31	Pliva Zagreb	Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
PL136968B1 (en) *	1983-02-10	1986-04-30	Tarchominskie Zaklad Farma	Process for preparing cyclic 11,12-carbonate of erythromycin a
JPS61103890A (ja) *	1984-10-26	1986-05-22	Taisho Pharmaceut Co Ltd	６−０−メチルエリスロマイシンａ誘導体
GB8506380D0 (en) *	1985-03-12	1985-04-11	Beecham Group Plc	Chemical compounds
US4670549A (en) *	1985-03-18	1987-06-02	Taisho Pharmaceutical Co., Ltd.	Method for selective methylation of erythromycin a derivatives
GB8521402D0 (en) *	1985-08-28	1985-10-02	Beecham Group Plc	Chemical compounds
DE3782994T2 (de) *	1986-09-18	1993-04-08	Taisho Pharma Co Ltd	Erythromycin-a-derivate und verfahren zu ihrer herstellung.
AU1204288A (en) *	1987-02-24	1988-08-25	Beecham Group Plc	Erythromycins
US4857641A (en) *	1987-08-14	1989-08-15	Pfizer Inc.	C.12 modified erythromycin A derivatives
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

1991
- 1991-11-07 IL IL99995A patent/IL99995A/xx not_active IP Right Cessation
- 1991-11-07 IL IL11458991A patent/IL114589A/en not_active IP Right Cessation
- 1991-11-19 MA MA22627A patent/MA22344A1/fr unknown
- 1991-11-20 SK SK3508-91A patent/SK281550B6/sk unknown
- 1991-11-20 PL PL91306130A patent/PL169422B1/pl not_active IP Right Cessation
- 1991-11-20 DK DK91403119.0T patent/DK0487411T3/da active
- 1991-11-20 PL PL91292455A patent/PL167448B1/pl not_active IP Right Cessation
- 1991-11-20 ES ES91403119T patent/ES2082952T3/es not_active Expired - Lifetime
- 1991-11-20 CZ CS19913508A patent/CZ290651B6/cs not_active IP Right Cessation
- 1991-11-20 EP EP91403119A patent/EP0487411B1/fr not_active Expired - Lifetime
- 1991-11-20 RU SU915010516A patent/RU2100367C1/ru not_active IP Right Cessation
- 1991-11-20 AT AT91403119T patent/ATE133683T1/de not_active IP Right Cessation
- 1991-11-20 AU AU87986/91A patent/AU640290B2/en not_active Expired
- 1991-11-20 DE DE69116815T patent/DE69116815T2/de not_active Expired - Lifetime
- 1991-11-20 FI FI915469A patent/FI102281B/fi not_active IP Right Cessation
- 1991-11-20 HU HU622/91A patent/HU218787B/hu not_active IP Right Cessation
- 1991-11-20 IE IE402991A patent/IE74713B1/en not_active IP Right Cessation
- 1991-11-20 KR KR1019910020684A patent/KR100189597B1/ko not_active Expired - Lifetime
- 1991-11-20 CA CA002055912A patent/CA2055912C/fr not_active Expired - Lifetime
- 1991-11-21 JP JP03331561A patent/JP3130097B2/ja not_active Expired - Lifetime
- 1991-11-21 MX MX9102159A patent/MX9102159A/es unknown
- 1991-11-21 PT PT99569A patent/PT99569B/pt not_active IP Right Cessation
- 1991-11-21 CN CN91111875A patent/CN1033974C/zh not_active Expired - Lifetime
- 1991-11-21 NZ NZ240684A patent/NZ240684A/en unknown
- 1991-11-21 BR BR919105062A patent/BR9105062A/pt not_active Application Discontinuation
- 1991-11-21 OA OA60098A patent/OA09523A/fr unknown
1993
- 1993-06-28 US US08/083,636 patent/US5444051A/en not_active Expired - Lifetime
1994
- 1994-03-31 US US08/220,484 patent/US5561118A/en not_active Expired - Lifetime
1995
- 1995-01-25 US US08/378,186 patent/US5770579A/en not_active Expired - Lifetime
- 1995-07-14 IL IL11458995A patent/IL114589A0/xx unknown
1996
- 1996-02-01 GR GR950401767T patent/GR3018848T3/el unknown

Also Published As

Publication number	Publication date
CZ290651B6 (cs)	2002-09-11
HU913622D0 (en)	1992-02-28
ES2082952T3 (es)	1996-04-01
CN1033974C (zh)	1997-02-05
AU640290B2 (en)	1993-08-19
FI915469A0 (fi)	1991-11-20
BR9105062A (pt)	1992-06-23
IE74713B1 (en)	1997-07-30
MA22344A1 (fr)	1992-07-01
FI102281B1 (fi)	1998-11-13
RU2100367C1 (ru)	1997-12-27
US5444051A (en)	1995-08-22
GR3018848T3 (en)	1996-05-31
DE69116815D1 (de)	1996-03-14
PL167448B1 (pl)	1995-09-30
CA2055912C (fr)	2002-03-19
AU8798691A (en)	1992-05-28
ATE133683T1 (de)	1996-02-15
FI915469A7 (fi)	1992-05-22
CN1065069A (zh)	1992-10-07
PT99569B (pt)	1999-04-30
IL99995A (en)	1997-11-20
JP3130097B2 (ja)	2001-01-31
PL169422B1 (pl)	1996-07-31
IE914029A1 (en)	1992-06-03
DE69116815T2 (de)	1996-10-17
US5770579A (en)	1998-06-23
EP0487411B1 (fr)	1996-01-31
SK281550B6 (sk)	2001-04-09
MX9102159A (es)	1992-07-08
CA2055912A1 (fr)	1992-05-21
US5561118A (en)	1996-10-01
FI102281B (fi)	1998-11-13
KR100189597B1 (ko)	1999-06-01
EP0487411A1 (fr)	1992-05-27
HUT61564A (en)	1993-01-28
IL99995A0 (en)	1992-08-18
OA09523A (fr)	1992-11-15
CS350891A3 (en)	1992-06-17
KR920009840A (ko)	1992-06-25
PL292455A1 (en)	1992-08-10
NZ240684A (en)	1994-08-26
IL114589A (en)	1999-12-22
HU218787B (hu)	2000-12-28
IL114589A0 (en)	1995-11-27
JPH04290893A (ja)	1992-10-15
DK0487411T3 (da)	1996-04-15

Legal Events

Date	Code	Title	Description
1992-10-30	BB1A	Laying open of patent application	Effective date: 19920601
1999-04-30	FG3A	Patent granted, date of granting	Effective date: 19990129
2000-01-31	PC3A	Transfer or assignment	Free format text: 19991011 HOECHST MARION ROUSSEL FR
2000-01-31	PD3A	Change of proprietorship	Owner name: ROUSSEL UCLAF Effective date: 19991011
2000-01-31	TE3A	Change of address (patent)	Owner name: ROUSSEL UCLAF Effective date: 19991011
2003-03-31	PC3A	Transfer or assignment	Free format text: AVENTIS PHARMA S.A. FR Effective date: 20030110
2014-02-05	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140129

Publication	Publication Date	Title
AU640290B2 (en)	1993-08-19	New erythromycin derivatives, their preparation process, the new intermediates obtained and their use as medicaments
PT99445A (pt)	1992-09-30	Processo para preparacao de derivados do 1,4,7,10-tetraazaciclododecano mono-n--substituidos e de composicoes farmaceuticas que os contem
ES2123039T3 (es)	1999-01-01	Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
PT93689A (pt)	1990-11-20	Processo para a preparacao de benzimidazois e de composicoes farmaceuticas que os contem
ES2081187T3 (es)	1996-02-16	Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
CO4290417A1 (es)	1996-04-17	Nuevas benzoilguanidinas como medicamentos y su preparacion .
ES2128519T3 (es)	1999-05-16	Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE150466T1 (de)	1997-04-15	Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon
ATE152707T1 (de)	1997-05-15	Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2111871T3 (es)	1998-03-16	Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES525441A0 (es)	1984-05-16	Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
PT97286A (pt)	1992-01-31	Processo para a preparacao de novos derivados do 3-aminocromano e de composicoes farmaceuticas que os contem
PT93915A (pt)	1990-11-20	Processo para a preparacao de novos derivados de 4-fenil-metil-1h-indol e de composicoes farmaceuticas que os contem
PT91873A (pt)	1990-04-30	Processo para a preparacao de composicoes farmaceuticas contendo acidos oxapenem-3-carboxilicos estaveis uteis como inibidores de beta-lactamase
ES2065192T3 (es)	1995-02-01	Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE71371T1 (de)	1992-01-15	Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
ATE56206T1 (de)	1990-09-15	N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel.
ES2103553T3 (es)	1997-09-16	Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2091670T3 (es)	1996-11-01	Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO961657D0 (no)	1996-04-25	Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike
ES2105569T3 (es)	1997-10-16	Nuevos analogos de metabolitos de acidos grasos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
PT97255A (pt)	1992-01-31	Processo para a preparacao de 3-tia-alquil-flavonas e de 3-oxa-alquil flavonas e substituidas e de composicoes farmaceuticas que as contem
ES2123038T3 (es)	1999-01-01	Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9204659A (es)	1993-12-31	Nuevas 3-(tetrazolil substituido)-oxo-4h-pirido-(1,2-a)-pirimidinas, sales de los mismos, las composiciones farmaceuticas que contienen a los mismos y procedimientos para prepararlas